Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015–2016

Background: Pakistan is one of the 3 remaining wild poliovirus endemic countries. We collected sera from children to assess the prevalence of poliovirus antibodies in selected high-risk areas for poliovirus transmission. Methods: Children in 2 age groups (6–11 and 36–48 months) were randomly selected between November 2015 and March 2016 in 6 areas of Pakistan (Sindh Province: Karachi and Kashmore; Khyber Pakhtunkhwa Province: Peshawar, Bannu and Nowshera; Punjab Province: Faisalabad). After obtaining informed consent, basic demographic and vaccination history data were collected, 1 peripheral venipuncture was obtained, and assays to detect poliovirus (PV)–neutralizing antibodies were performed. Results: A total of 1301 children were enrolled and had peripheral blood drawn that analyzed. Study subjects were evenly distributed among survey sites and age groups. Anti-polio seroprevalence differed significantly among geographic areas (P < 0.001); in the 6–11 months group, it ranged between 89% and 98%, 58% and 95%, and 74% and 96% for PV serotypes 1, 2 and 3, respectively; in 36–48 months group, it ranged between 99% and 100%, 95% and 100%, and 92% and 100% for PV 1, 2, and 3, respectively. Having received inactivate poliovirus vaccine, malnourishment (stunting) and educational level of parents were found to be associated with presence of anti-polio antibodies. Conclusion: The polio eradication program achieved overall high serologic protection; however, immunity gaps in young children in the high polio risk areas remain. These gaps enable sustained circulation of wild poliovirus type 1, and pose risk for emergence of vaccine-derived polioviruses. Focusing on the lowest socioeconomic strata of society, where malnutrition is most prevalent, could accelerate poliovirus eradication.

[1]  Steven G F Wassilak,et al.  Progress Toward Polio Eradication - Worldwide, 2015-2016. , 2016 .

[2]  S. Chu,et al.  The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal. , 2016, Vaccine.

[3]  M. Pallansch,et al.  Standardized Methods for Detection of Poliovirus Antibodies. , 2016, Methods in molecular biology.

[4]  W. Weldon,et al.  Achieving high seroprevalence against polioviruses in Sri Lanka-Results from a serological survey, 2014 , 2015, Journal of epidemiology and global health.

[5]  W. Weldon,et al.  Immunogenicity of poliovirus vaccines in chronically malnourished infants: A randomized controlled trial in Pakistan , 2015, Vaccine.

[6]  K. Wannemuehler,et al.  Cross-sectional serologic assessment of immunity to poliovirus infection in high-risk areas of northern India. , 2014, The Journal of infectious diseases.

[7]  M. Pallansch,et al.  Assessing population immunity in a persistently high-risk area for wild poliovirus transmission in India: a serological study in Moradabad, Western Uttar Pradesh. , 2014, The Journal of infectious diseases.

[8]  L. Moulton,et al.  Effect of buffer on the immune response to trivalent oral poliovirus vaccine in Bangladesh: a community based randomized controlled trial. , 2014, The Journal of infectious diseases.

[9]  An acute flaccid paralysis surveillance-based serosurvey of poliovirus antibodies in Western Uttar Pradesh, India. , 2014, The Journal of infectious diseases.

[10]  Roland W Sutter,et al.  The new polio eradication end game: rationale and supporting evidence. , 2014, The Journal of infectious diseases.

[11]  G. Kang,et al.  Influence of Enteric Infections on Response to Oral Poliovirus Vaccine: A Systematic Review and Meta-analysis , 2014, The Journal of infectious diseases.

[12]  K. Wannemuehler,et al.  Combined Use of Inactivated and Oral Poliovirus Vaccines in Refugee Camps and Surrounding Communities — Kenya, December 2013 , 2014, MMWR. Morbidity and mortality weekly report.

[13]  R. Kaur,et al.  India's poliomyelitis eradication: a milestone in public health. , 2013, Journal of tropical pediatrics.

[14]  Z. Bhutta,et al.  A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan. , 2013, Vaccine.

[15]  R. Sutter,et al.  28 – Poliovirus vaccine—live , 2013 .

[16]  M. Pallansch,et al.  Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. , 2012, The Lancet. Infectious diseases.

[17]  M. Onis,et al.  Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. , 1996, The American journal of clinical nutrition.

[18]  Nutritional anaemias. Report of a WHO scientific group. , 1968, World Health Organization technical report series.